Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2016 12:10 ET | Source: Cannabis Science, Inc.

Cannabis Science to Begin In-House Clinical Research With IGXBio's GenePro FDA Investigational New Drug (IND) Number 015982 for further Drug Development to Identify & Develop Agonist Cannabinoids for GenePro

IRVINE, CA--(Marketwired - Nov 3, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces that its in-house lab is...
November 03, 2016 12:00 ET | Source: Ancestry.com LLC

Ancestry Lands Science and Data Industry Veterans; Bolsters Recruiting Efforts

LEHI, Utah and SAN FRANCISCO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Ancestry, the global leader in family history and consumer genomics, today announced three new appointments to its growing...
November 03, 2016 10:32 ET | Source: Ancestry.com LLC

UPDATE – Ancestry.com LLC Announces Participation in Morgan Stanley Leveraged Finance Conference

LEHI, Utah, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Ancestry, the global leader in family history and consumer genomics, today announced its expected participation in the following investor...
November 03, 2016 09:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics to Present Three Abstracts on Novel BCMA-Specific CAR-T Therapy at American Society of Hematology 2016 Annual Meeting

SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today...
November 03, 2016 08:32 ET | Source: Inivata

Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients

RESEARCH TRIANGLE PARK, N.C., CAMBRIDGE, England, and CONCORD, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Inivata, a global clinical cancer genomics company employing a revolutionary approach to...
November 03, 2016 08:02 ET | Source: Celtaxsys, Inc.

Celtaxsys Announces Publication of Clinical Trial Results Demonstrating Its Novel Anti-inflammatory Medicine, Oral Acebilustat, Markedly Reduced Lung Inflammation Without Increased Risk of Immunosuppression, in Patients with Cystic Fibrosis (CF)

ATLANTA, GA--(Marketwired - November 03, 2016) - Celtaxsys, Inc., a clinical stage drug development company advancing therapies for patients with rare inflammatory diseases, announced today the...
November 03, 2016 08:00 ET | Source: Nurse Next Door

Nurse Next Door Named Winner Of The 2016 Pacific EY Entrepreneur Of The Year Healthcare Services Award

VANCOUVER, BC--(Marketwired - November 03, 2016) - Nurse Next Door was named winner in the Healthcare Services category of the 23rd Pacific EY Entrepreneur Of The Year™ awards program during a gala...
November 03, 2016 08:00 ET | Source: mdxhealth

MDxHealth Successfully Raises EUR 20.4 million (USD 22.6 million) In Equity Placement

THIS ANNOUCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURIDICTION WHERE TO DO SO WOULD BE...
November 03, 2016 08:00 ET | Source: Interleukin Genetics, Inc.

Interleukin Genetics Launches The ILUSTRA™ Inflammation Management Program

WALTHAM, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Interleukin Genetics, Inc. (OTCQB:ILIU) a life science company focused on the genetics of chronic inflammation, today unveiled the ILUSTRA™...
November 03, 2016 08:00 ET | Source: Celsion Corporation

Celsion Corporation to Hold Third Quarter 2016 Financial Results Conference Call on Thursday, November 10, 2016

LAWRENCEVILLE, N.J., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN) announced today that the Company will host a conference call to discuss financial results for the quarter and...